Opposition Members of Parliament in New Zealand did not allege that the 2024 pseudoephedrine bill was influenced by pharmaceutical company lobbying or electoral deal-making. Instead, they expressed concerns that community pharmacists would face increased risks of crime due to the deregulation. MPs also criticized the truncated select committee process and the lack of harm mitigation measures, while still supporting the bill's aim to improve access to cold remedies. AI
IMPACT Provides insight into legislative processes and public health policy debates in New Zealand.
RANK_REASON Analysis of parliamentary records regarding a specific piece of legislation. [lever_c_demoted from research: ic=1 ai=0.4]
- ACT New Zealand
- Ayesha Verrall
- Chlöe Swarbrick
- David Seymour
- Debbie Ngarewa-Packer
- Ingrid Leary
- Labour Party
- Medsafe
- Misuse of Drugs Act 1975
- Misuse of Drugs (Pseudoephedrine) Amendment Bill
- New Zealand Hansard
- Takutai Tarsh Kemp
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
